Twist Bioscience Corp [TWST] stock prices are down -6.53% to $40.36 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The TWST shares have gain 0.30% over the last week, with a monthly amount drifted -6.75%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Twist Bioscience Corp [NASDAQ: TWST] stock has seen the most recent analyst activity on June 04, 2024, when Guggenheim initiated its Buy rating and assigned the stock a price target of $53. Previously, Goldman upgraded its rating to Buy on January 17, 2024, and elevated its price target to $45. On September 27, 2023, Berenberg initiated with a Buy rating and assigned a price target of $27 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating and suggested a price target of $33 on January 05, 2023. Evercore ISI upgraded its rating to a Outperform and raised its price target to $36 on January 03, 2023.
The stock price of Twist Bioscience Corp [TWST] has been fluctuating between $15.11 and $60.90 over the past year. Currently, Wall Street analysts expect the stock to reach $42.4 within the next 12 months. Twist Bioscience Corp [NASDAQ: TWST] shares were valued at $40.36 at the most recent close of the market. An investor can expect a potential return of 5.05% based on the average TWST price forecast.
Analyzing the TWST fundamentals
The Twist Bioscience Corp [NASDAQ:TWST] reported sales of 295.21M for trailing twelve months, representing a surge of 27.81%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at -0.64%, Pretax Profit Margin comes in at -0.74%, and Net Profit Margin reading is -0.75%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.39 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 39.56 points at the first support level, and at 38.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 41.93, and for the 2nd resistance point, it is at 43.49.
Ratios To Look Out For
It’s worth pointing out that Twist Bioscience Corp [NASDAQ:TWST]’s Current Ratio is 4.91. On the other hand, the Quick Ratio is 4.52, and the Cash Ratio is 3.24. Considering the valuation of this stock, the price to sales ratio is 8.01, the price to book ratio is 4.81.
Transactions by insiders
Recent insider trading involved Finn Patrick John, President and COO, that happened on Oct 23 ’24 when 2261.0 shares were sold. Officer, Finn Patrick John completed a deal on Oct 23 ’24 to buy 2261.0 shares. Meanwhile, Chief Financial Officer Laponis Adam sold 856.0 shares on Oct 09 ’24.
